Postmenopausal hormone therapy and coronary heart disease -: clinical implications of recent randomized trial results by Leon!Speroff -: Published in:: Maturitas 2000;35:91-97 -: Comment by M.J.!van der Mooren, Amsterdam (The Netherlands)

被引：0
作者：
van der Mooren, J [1 ]
机构：
[1] Univ Hosp Vrije Univ, Dept Obstet & Gynaecol, Amsterdam, Netherlands
来源：
MATURITAS | 2000年 / 35卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 5 条
  • [1] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    Hulley, S
    Grady, D
    Bush, T
    Furberg, C
    Herrington, D
    Riggs, B
    Vittinghoff, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
  • [2] RIDKER PM, NEW ENGL J MED, V2105, P836
  • [3] SHLIPAK MG, J AM MED ASS, V235, P1845
  • [4] Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women
    van Baal, WM
    Kenemans, P
    van der Mooren, MJ
    Kessel, H
    Emeis, JJ
    Stehouwer, CDA
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 81 (06) : 925 - 928
  • [5] Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease
    van der Mooren, MJ
    Mijatovic, V
    van Baal, WM
    Stehouwer, CDA
    [J]. MATURITAS, 1998, 30 (01) : 27 - 36
1